Table 2.
Blood Pressure Measured at the Baseline Exam and Antihypertensive Medication Among Hypertensive Cohort Members (Top), and Fasting Glucose Among Diabetic Cohort Members (Bottom)
| American Indian | Black | White | |
|---|---|---|---|
| People with hypertensiona | (n=1172) | (n=2155) | (n=3298) |
| Blood pressure at exam | |||
| Systolic, mean mm Hg (SD) | 142 (20) | 137 (23) | 130 (20) |
| Diastolic, mean mm Hg (SD) | 82 (11) | 84 (13) | 76 (11) |
| Medication and controlb | |||
| No medication, n (%) | 464 (40) | 535 (25) | 723 (22) |
| Medicated, poor control, n (%) | 308 (26) | 603 (28) | 560 (17) |
| Medicated, good control, n (%) | 400 (34) | 1017 (47) | 2015 (61) |
| People with diabetes mellitusc | (n=1144) | (n=680) | (n=811) |
| Fasting glucose at exam, mean mg/dL (SD) | 207 (75) | 200 (87) | 172 (66) |
| Fasting glucose ≤125 mg/dL, n (%) | 31 (3) | 71 (10) | 90 (11) |
a
Results presented only for people with prevalent hypertension at their baseline exam,
b
Medication=antihypertensive drugs; good control=blood pressure <140/90 mm Hg at baseline exam; poor control=blood pressure ≥140/90 at baseline exam.
c
Results presented only for people with prevalent diabetes mellitus at their baseline exam.